Double maintains 3 strategies that include ROIV - Roivant Sciences Ltd.
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| VIXY | -44.97% | $164.54M | 0.85% |
| TAIL | -44.45% | $99.63M | 0.59% |
| BTAL | -36.57% | $296.22M | 1.43% |
| IVOL | -18.00% | $347.03M | 1.02% |
| XHLF | -14.15% | $1.73B | 0.03% |
| FTSD | -12.84% | $231.81M | 0.25% |
| KCCA | -12.64% | $109.43M | 0.87% |
| TFLO | -12.21% | $6.82B | 0.15% |
| FXY | -11.13% | $816.38M | 0.4% |
| XONE | -10.31% | $625.28M | 0.03% |
| ULST | -9.98% | $654.75M | 0.2% |
| TBLL | -9.35% | $2.13B | 0.08% |
| BIL | -9.02% | $42.24B | 0.1356% |
| BILS | -9.01% | $3.81B | 0.1356% |
| TPMN | -8.14% | $30.70M | 0.65% |
| SPTS | -8.02% | $5.80B | 0.03% |
| SCHO | -6.35% | $11.03B | 0.03% |
| IBTG | -5.77% | $1.92B | 0.07% |
| GBIL | -4.97% | $6.37B | 0.12% |
| UTWO | -4.63% | $379.52M | 0.15% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| STG | -8.34% | $30.78M | -22.51% | 0.00% |
| VSA | -7.96% | $8.67M | -19.04% | 0.00% |
| CBOE | -6.30% | $24.23B | +35.36% | 1.09% |
| DFDV | -5.50% | $300.56M | +2,130.16% | 0.00% |
| LITB | -4.82% | $21.24M | -78.57% | 0.00% |
| PSQH | -4.61% | $98.82M | -36.55% | 0.00% |
| CARV | -4.31% | $8.88M | +26.23% | 0.00% |
| RRGB | -3.61% | $122.20M | +4.87% | 0.00% |
| K | -2.68% | $27.76B | +41.17% | 2.85% |
| NEUE | -2.25% | $61.24M | +29.92% | 0.00% |
| CCRN | -2.02% | $429.13M | -3.89% | 0.00% |
| AGL | -2.02% | $989.35M | -60.10% | 0.00% |
| UUU | -2.01% | $7.17M | +101.30% | 0.00% |
| VHC | -1.40% | $48.19M | +108.24% | 0.00% |
| ZCMD | -1.40% | $29.55M | -8.59% | 0.00% |
| HUSA | -0.67% | $19.66M | -19.53% | 0.00% |
| TU | -0.60% | $24.75B | +7.77% | 7.12% |
| FUBO | -0.48% | $1.25B | +178.63% | 0.00% |
| MSEX | -0.38% | $1.00B | +5.97% | 2.41% |
| LTM | -0.37% | $12.63B | -95.46% | 2.42% |
SeekingAlpha
Roivant Sciences: Booming Pipeline Without Product Revenues Creates Valuation Riddle
Yahoo
Roivant Sciences Ltd. (NASDAQ:ROIV) is one of the best biotech stocks to invest in now. On June 16, Pulmovant, a Roivant company, announced the publication of Phase 1 pharmacokinetic/PK data for inhaled mosliciguat in healthy male volunteers. The peer-reviewed manuscript, titled “Pharmacokinetics and Lung Deposition After Administration of Inhaled Mosliciguat (BAY 1237592): Results from Randomized […]
SeekingAlpha
Greenlight Capital outperforms with an 8.2% Q1 2025 return. Check out the major stake increases and selective trims in the portfolio.
Finnhub
Brepocitinib: Investor Event Seeking to improve the lives of patients with DM and other serious autoimmune conditions June 17, 2025 ...
Finnhub
WALTHAM - Pulmovant, a clinical-stage biotechnology company dedicated to developing innovative therapies to transform the treatment paradigm for adults suffering from pulmonary diseases and a Roivant ...
SeekingAlpha
The fund outperformed the benchmark during the last quarter. From a sector perspective, Energy was at the forefront of index returns as global oil prices rallied.
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| IBTK | -0.02% | $448.89M | 0.07% |
| IBTJ | -0.27% | $688.19M | 0.07% |
| UDN | 0.31% | $148.33M | 0.78% |
| IEI | 0.37% | $15.48B | 0.15% |
| STOT | -0.59% | $254.07M | 0.45% |
| IBDQ | -0.60% | $2.98B | 0.1% |
| UUP | 0.71% | $201.63M | 0.77% |
| CARY | -0.96% | $347.36M | 0.8% |
| IBTF | 0.99% | $1.99B | 0.07% |
| CANE | -1.04% | $10.37M | 0.29% |
| PSQA | 1.13% | $35.44M | 0.2% |
| FXE | -1.20% | $568.94M | 0.4% |
| STPZ | -1.24% | $450.47M | 0.2% |
| BSCP | 1.27% | $3.28B | 0.1% |
| VGIT | 1.31% | $31.89B | 0.04% |
| SGOV | 1.31% | $49.21B | 0.09% |
| BUXX | 1.35% | $315.18M | 0.25% |
| UNG | -1.39% | $360.54M | 1.06% |
| CTA | -1.68% | $1.06B | 0.76% |
| WEAT | 1.71% | $117.15M | 0.28% |
Current Value
$11.011 Year Return
Current Value
$11.011 Year Return
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| XBI | 69.41% | $4.82B | 0.35% |
| IBB | 65.92% | $5.26B | 0.45% |
| BBH | 60.28% | $330.62M | 0.35% |
| FBT | 59.69% | $1.01B | 0.54% |
| GNOM | 58.42% | $44.57M | 0.5% |
| PBE | 58.25% | $223.19M | 0.58% |
| PTH | 57.39% | $100.85M | 0.6% |
| XT | 57.22% | $3.40B | 0.46% |
| QQQJ | 57.09% | $621.52M | 0.15% |
| CGBL | 56.96% | $2.57B | 0.33% |
| VT | 56.74% | $48.65B | 0.06% |
| DUHP | 56.68% | $8.66B | 0.21% |
| SUSA | 56.66% | $3.58B | 0.25% |
| URTH | 56.63% | $4.99B | 0.24% |
| USPX | 56.53% | $1.26B | 0.03% |
| ACWI | 56.42% | $22.25B | 0.32% |
| ITOT | 56.35% | $70.29B | 0.03% |
| FLQL | 56.31% | $1.52B | 0.29% |
| FQAL | 56.31% | $1.04B | 0.16% |
| TSPA | 56.24% | $1.78B | 0.34% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| HAIN | 0.06% | $149.82M | -76.22% | 0.00% |
| VSTA | 0.07% | $344.07M | +39.29% | 0.00% |
| EXC | 0.11% | $43.33B | +23.58% | 3.62% |
| AWK | -0.18% | $27.36B | +9.65% | 2.21% |
| OXBR | 0.22% | $16.90M | +1.79% | 0.00% |
| OCFT | -0.24% | $267.49M | +332.74% | 0.00% |
| LTM | -0.37% | $12.63B | -95.46% | 2.42% |
| MSEX | -0.38% | $1.00B | +5.97% | 2.41% |
| PRPO | 0.47% | $17.08M | +125.94% | 0.00% |
| FUBO | -0.48% | $1.25B | +178.63% | 0.00% |
| NEOG | 0.54% | $1.14B | -65.61% | 0.00% |
| TU | -0.60% | $24.75B | +7.77% | 7.12% |
| HUSA | -0.67% | $19.66M | -19.53% | 0.00% |
| DG | 0.73% | $25.41B | -7.95% | 2.05% |
| UTZ | 0.74% | $1.14B | -19.23% | 1.82% |
| CYCN | 0.77% | $10.59M | +46.35% | 0.00% |
| KR | 0.96% | $46.43B | +38.38% | 1.85% |
| MCK | 0.96% | $88.11B | +20.93% | 0.40% |
| MSIF | 1.38% | $769.47M | +36.17% | 7.61% |
| ZCMD | -1.40% | $29.55M | -8.59% | 0.00% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| IMVT | 61.72% | $2.87B | -35.84% | 0.00% |
| ACLX | 53.34% | $3.66B | +21.24% | 0.00% |
| BN | 52.66% | $103.22B | +45.48% | 0.54% |
| CRH | 51.48% | $63.86B | +28.79% | 0.39% |
| CRNX | 51.30% | $2.76B | -33.39% | 0.00% |
| BNT | 50.99% | $12.59B | +45.18% | 0.00% |
| KRYS | 50.20% | $4.08B | -20.39% | 0.00% |
| CGON | 49.68% | $2.03B | -13.46% | 0.00% |
| MFA | 49.44% | $996.76M | -7.87% | 14.52% |
| OCUL | 49.00% | $1.51B | +41.41% | 0.00% |
| DYN | 48.52% | $1.02B | -73.78% | 0.00% |
| RITM | 48.34% | $6.19B | +9.67% | 8.53% |
| NDSN | 48.33% | $12.59B | -2.13% | 1.39% |
| AMKR | 48.14% | $5.51B | -43.82% | 1.46% |
| DNLI | 48.12% | $2.16B | -30.05% | 0.00% |
| PH | 48.01% | $90.91B | +38.76% | 0.94% |
| RNA | 47.86% | $3.54B | -21.10% | 0.00% |
| APH | 47.66% | $119.17B | +45.33% | 0.67% |
| NCV | 47.65% | - | - | 6.48% |
| ENTG | 47.64% | $13.09B | -38.54% | 0.46% |
